Lexicon submits additional data for its diabetes drug to US FDA-March 2024-www.financetom.com

Lexicon submits additional data for its diabetes drug to US FDA

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Lexicon submits additional data for its diabetes drug to US FDA

Mar 10, 2026 8:21 PM

Sept 22 (Reuters) - Lexicon Pharmaceuticals ( LXRX )

said on Monday it had submitted supplementary data to the U.S.

Food and Drug Administration to enhance the benefit-risk profile

of its experimental drug, zynquista, for patients with type 1

diabetes.

Previous page： Form 8.3 - Bakkavor Group PLC Next page： Form 8.3 - Deliveroo PLC

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3 - Bakkavor Group PLC

Sep 30, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

Form 8.3 - Deliveroo PLC

Sep 30, 2025

Manifest Financial Acquires Nucreator to Power Brand Partnership Discovery for Creators

Sep 30, 2025

Acquisition brings AI-powered brand partnership tools to Manifest platform, helping creators find and close deals faster LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- Manifest Financial, the financial solutions platform built exclusively for creators, today announced that it has acquired Nucreator, an AI-powered platform that helps content creators and talent managers proactively discover and secure brand partnerships. This acquisition expands...

Blue Water Moves to Secure Court Approval for $10 Billion CITGO Acquisition Plan

Sep 30, 2025

WILMINGTON, Del., Sept. 30, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC (Blue Water), an entity affiliated with Joseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp III ( BLUW ) (BWAC III) announced today that it has formally requested approval from the United States District Court for the District of Delaware to consider its unsolicited...